TNF and COVID-19: An ex vivo study of NK cells from the peripheral blood of patients with COVID-19 revealed a decrease in the expression of CD107a, caspase Ksp37, granzyme B, and granulysin; these changes could result in reduced cytotoxicity and insufficient production of IFN-γ and TNF-α [31,32].